MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD

Respiratory Medicine

Volumn 102, Issue 6, 2008, Pages 845-851

  Lowrey, Gillian E ^a,b   Henderson, Neil ^b   Blakey, John D ^b   Corne, Jonathan M ^a   Johnson, Simon R ^b  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Chronic obstructive pulmonary disease; Induced sputum; Matrix metalloproteinase; Tissue inhibitors of matrix metalloproteinases

Indexed keywords

COLLAGENASE; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SPUTUM; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; COLLAGENASES; FEMALE; FORCED EXPIRATORY VOLUME; GELATINASES; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; PANCREATIC ELASTASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPUTUM; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; VITAL CAPACITY;

EID: 43049143348     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.01.006     Document Type: Article

References (24)

1. World Health Organization: Global Initiative for Chronic Obstructive Lung Disease. Update July 2004.
2. Laurell C.B., and Erickson S. The electrophoretic alpha-1 globulin pattern of serum in alpha-1 antitrypsin deficiency. Scand J Clin Lab Invest 15 (1963) 132-140
3. Hautamaki R., and Shapiro S. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277 (1997) 2002-2005
4. Wang Z., Zheng T., and Elias J. Interferon-gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 192 11 (2000) 1587-1599
5. Zheng T., Zhu Z., Wang Z., et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 106 (2000) 1081-1093
6. Lanone S., Zheng T., Zhu Z., et al. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodelling. J Clin Invest 110 (2002) 463-474
7. Leco K.J., Waterhouse P., Sanchez O.H., et al. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest 108 (2001) 817-829
8. Prause O., Bozinovski S., Anderson G.P., et al. Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax 59 (2004) 313-317
9. Ohnishi K., Takagi M., Kurokawa Y., et al. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 78 (1998) 1077-1087
10. Culpitt S.V., Maziak W., Loukidis S., et al. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999) 1635-1639
11. Russell R.E., Culpitt S.V., DeMatos C., et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 26 (2002) 602-609
12. Segura-Valdez L., Pardo A., Gaxiola M., et al. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 117 (2000) 684-694
13. Vernooy J.H.J., Lindeman J.H.N., Jacobs J.A., et al. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD. Chest 126 (2004) 1802-1810
14. Vignola A., and Riccobono L.R. Sputum MMP-9/TIMP ratio correlates with airflow obstruction in asthma and COPD. Am J Respir Crit Care Med 158 (1998) 1945-1950
15. Imai K., Dalal S.S., Chen E.S., et al. Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med 163 (2001) 786-791
16. Beeh K.M., Beier J., Kornmann O., et al. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects. Respir Med 97 (2003) 634-639
17. Betsuyaku T., and Nishimura M.M. Neutrophil granule proteins in BAL fluid from subjects with sub clinical emphysema. Am J Respir Crit Care Med 159 (1999) 1985-1991
18. Cataldo D., Munaut C., Noel A., et al. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 123 (2000) 259-267
19. Finlay G., and O'Driscoll L. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 156 (1997) 240-247
20. Finlay G., and Russell K.J. Elevated levels of MMPs in BAL fluid of emphysematous patients. Thorax 52 (1997) 502-506
21. Pin I., and Kolendowicz R. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47 (1992) 25-29
22. Pavord I.D., Pizzichini M.M., Pizzichini E., et al. The use of induced sputum to investigate airway inflammation. Thorax 52 (1997) 498-501
23. Elshaw S.R., Henderson N., Knox A.J., et al. Matrix metalloproteinase expression and activity in human airway smooth muscle cells. Br J Pharmacol 142 (2004) 1318-1324
24. Mercer F., Shute J., Bhowmik A., Donaldson G., Wedzicha J., and Warner J. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation. Respir Res 6 (2005) 10.1186/1465-9921-1186-1151